Our latest work highlights how menopause alters insulin sensitivity and diabetes management, yet the intersection remains under-researched. This study explores how menopause stages impact diabetes outcomes.
This white paper outlines how psychographics reveal the drivers behind diabetes patient behaviors, helping predict actions and guide better decisions.
This survey shows COVID-19 booster rates are higher in U.S. adults with diabetes than the general population, but vary by race, income, and location.
We surveyed panel members about the FDA advisory on Provention Bio’s teplizumab to delay type 1 diabetes—discover their top concerns and expected impact.
This research reveals how stigma in diabetes—from HCPs and society—affects relationships, care decisions, mental health, and diabetes management.
ADA and dQ&A survey results reveal that COVID fears kept one in five people with diabetes away from the doctor during the pandemic.
Which diabetes groups lead or lag on COVID-19 shots? See dQ&A’s panel results from March 2021 and uncover barriers to higher coverage.
Our survey finds major pharmacies often fail people with diabetes, with wide NPS score gaps; Sam’s Club, Publix, Costco, and U.S. Medical Supply rank highest.
5,700 dQ&A community members share where they were diagnosed, first symptoms, and emotions—highlighting key differences between type 1 and type 2 journeys.
